Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells

This publication has 37 references indexed in Scilit:

• Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate
  Molecular and Cellular Endocrinology, 1990
• Effects of sex steroids on regulation of the levels of Cl peptide of rat prostatic steroid-binding protein mRNA evaluated by in-situ hybridization
  Journal of Molecular Endocrinology, 1988
• Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture
  The Journal of Steroid Biochemistry and Molecular Biology, 1988
• Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line
  Breast Cancer Research and Treatment, 1988
• Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol red
  The Journal of Steroid Biochemistry and Molecular Biology, 1988
• Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive shionogi tumor in mice
  Journal of Steroid Biochemistry, 1988
• Breast gross cystic disease protein 15 in human breast cancer in culture
  European Journal of Cancer and Clinical Oncology, 1988
• Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells
  Breast Cancer Research and Treatment, 1987
• Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma
  Breast Cancer Research and Treatment, 1986
• A 250-kilodalton cellular protein is induced by progestins in two human breast cancer cell lines MCF7 and T47D
  Biochemical and Biophysical Research Communications, 1984